The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Open accessAbstract
Angiogenesis is the process in which new vessels emerge from existing endothelial lined vessels. This is distinct from the process of vasculogenesis in that the endothelial cells arise by proliferation from existing vessels rather than differentiating from stem cells. Angiogenesis is an invasive process that requires proteolysis of the extracellular matrix and, proliferation and migration of endothelial cells, as well as synthesis of new matrix components. During embryonic development, both vasculogenesis and angiogenesis contribute to formation of the circulatory system. In the adult, with the single exception of the reproductive cycle in women, angiogenesis is initiated only in response to a pathologic condition, such as inflammation or hypoxia. The angiogenic response is critical for progression of wound healing and rheumatoid arthritis. Angiogenesis is also a prerequisite for tumor growth and metastasis formation. Therefore, understanding the cellular events involved in angiogenesis and the molecular regulation of these events has enormous clinical implications. This understanding is providing novel therapeutic targets for the treatment of a variety of diseases, including cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Self-citationECM and Cell Surface Proteolysis: Regulating Cellular Ecology
Werb, Z. (1997) · Cell · doi:10.1016/s0092-8674(00)80429-8 · Cited by 1,307
Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., & Quaranta, V. (1997) · Science · doi:10.1126/science.277.5323.225 · Cited by 1,221
Self-citationReduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation
Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17124 · Cited by 747
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Whitelock, J. M., Murdoch, A. D., Iozzo, R. V., & Underwood, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10079 · Cited by 597
Cited by
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J. C., Arana-Argáez, V., Lara-Riegos, J., Ramírez-Camacho, M. A., & Alvarez-Sánchez, M. E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01370 · Cited by 1,036
Matrix metalloproteinases and angiogenesis
Rundhaug, J. E. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00355.x · Cited by 960
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Matrix metalloproteinases: multifunctional contributors to tumor progression
McCawley, L. J., & Matrisian, L. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01686-5 · Cited by 643
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
Duffy, M. J., Maguire, T. M., Hill, A., McDermott, E., & O'Higgins, N. (2000) · Breast Cancer Research · doi:10.1186/bcr65 · Cited by 628
Yoon, C.-H., Hur, J., Park, K.-W., Kim, J.-H., Lee, C.-S., Oh, I.-Y., Kim, T.-Y., Cho, H.-J., Kang, H.-J., Chae, I.-H., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.503433 · Cited by 601
Taraboletti, G., D'Ascenzo, S., Borsotti, P., Giavazzi, R., Pavan, A., & Dolo, V. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64887-0 · Cited by 588
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Zucker, S., Cao, J., & Chen, W.-T. (2000) · Oncogene · doi:10.1038/sj.onc.1204097 · Cited by 550
Roles for Growth Factors in Cancer Progression
Witsch, E., Sela, M., & Yarden, Y. (2010) · Physiology · doi:10.1152/physiol.00045.2009 · Cited by 526
Extracellular matrix remodelling and cellular differentiation
Streuli, C. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00026-5 · Cited by 512
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.002 · Cited by 504
Stetler-Stevenson, W. G. (2008) · Science Signaling · doi:10.1126/scisignal.127re6 · Cited by 489
Self-citationXu, J., Rodriguez, D., Petitclerc, E., Kim, J. J., Hangai, M., Yuen, S. M., Davis, G. E., & Brooks, P. C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103111 · Cited by 489
Heparanase: a key enzyme involved in cell invasion
Parish, C. R., Freeman, C., & Hulett, M. D. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00017-8 · Cited by 466
Park, H.-Y., Kwon, H. M., Lim, H. J., Hong, B. K., Lee, J. Y., Park, B. E., Jang, Y. S., Cho, S. Y., & Kim, H.-S. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.17 · Cited by 464
Chung, T., Moon, S., Chang, Y., Ko, J., Lee, Y., Cho, G., Kim, S., Kim, J., & Kim, C. (2004) · The FASEB Journal · doi:10.1096/fj.04-2126com · Cited by 456
Matrix Metalloproteinases in Human Melanoma
Hofmann, U. B., Westphal, J. R., van Muijen, G. N. P., & Ruiter, D. J. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00068.x · Cited by 425
Proteases in invasion: matrix metalloproteinases
Stetler-Stevenson, W. G., & Yu, A. E. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0365 · Cited by 411
Self-citationNovel functions of TIMPs in cell signaling
Chirco, R., Liu, X.-W., Jung, K.-K., & Kim, H.-R. C. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7893-x · Cited by 401
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
Fang, J., Shing, Y., Wiederschain, D., Yan, L., Butterfield, C., Jackson, G., Harper, J., Tamvakopoulos, G., & Moses, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3884 · Cited by 393
Generation and degradation of human endostatin proteins by various proteinases
Ferreras, M., Felbor, U., Lenhard, T., Olsen, B. R., & Delaissé, J.-M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02249-3 · Cited by 377
Mathematical modeling of tumor-induced angiogenesis
Mantzaris, N. V., Webb, S., & Othmer, H. G. (2004) · Journal of Mathematical Biology · doi:10.1007/s00285-003-0262-2 · Cited by 362
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.001 · Cited by 350
The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis
Liang, W., & Ferrara, N. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0313 · Cited by 347
Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer
Kerkelä, E., & Saarialho‐Kere, U. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.120201.x · Cited by 345
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338
Wang, L., Zhang, Z. G., Zhang, R. L., Gregg, S. R., Hozeska-Solgot, A., LeTourneau, Y., Wang, Y., & Chopp, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5380-05.2006 · Cited by 316
Heparanase as mediator of angiogenesis: mode of action
Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., & Vlodavsky, I. (2001) · The FASEB Journal · doi:10.1096/fj.00-0895fje · Cited by 310
Angiogenic Role of LYVE-1–Positive Macrophages in Adipose Tissue
Cho, C.-H., Jun Koh, Y., Han, J., Sung, H.-K., Jong Lee, H., Morisada, T., Schwendener, R. A., Brekken, R. A., Kang, G., Oike, Y., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000259564.92792.93 · Cited by 309
Sgadari, C., Barillari, G., Toschi, E., Carlei, D., Bacigalupo, I., Baccarini, S., Palladino, C., Leone, P., Bugarini, R., Malavasi, L., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-225 · Cited by 309
Human endothelial gelatinases and angiogenesis
Nguyen, M. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00007-3 · Cited by 300
A Cell-Based Model Exhibiting Branching and Anastomosis during Tumor-Induced Angiogenesis
Bauer, A. L., Jackson, T. L., & Jiang, Y. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.101501 · Cited by 297
Working hypothesis to redefine endothelial progenitor cells
Prater, D. N., Case, J., Ingram, D. A., & Yoder, M. C. (2007) · Leukemia · doi:10.1038/sj.leu.2404676 · Cited by 293
Fernández, C. A., Yan, L., Louis, G., Yang, J., Kutok, J. L., & Moses, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2391 · Cited by 283
Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schäfer, R., Stanley, E. R., & Abraham, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0961 · Cited by 281
Maquoi, E., Munaut, C., Colige, A., Collen, D., & Lijnen, H. R. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1093 · Cited by 271
Study of matrix metalloproteinases and their inhibitors in breast cancer
Vizoso, F. J., González, L. O., Corte, M. D., Rodríguez, J. C., Vázquez, J., Lamelas, M. L., Junquera, S., Merino, A. M., & García-Muñiz, J. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603666 · Cited by 271
Cui, Z., Crane, J., Xie, H., Jin, X., Zhen, G., Li, C., Xie, L., Wang, L., Bian, Q., Qiu, T., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207923 · Cited by 268
Silletti, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262
Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis
Foda, H. D., & Zucker, S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01752-4 · Cited by 262
Subcutaneous fat in normal and diseased states
Avram, M. M., Avram, A. S., & James, W. D. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.022 · Cited by 261
Sounni, N. E., Devy, L., Hajitou, A., Frankenne, F., Munaut, C., Gilles, C., Deroanne, C., Thompson, E. W., Foidart, J. M., & Noel, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0790com · Cited by 260
Hur, J., Yang, H.-M., Yoon, C.-H., Lee, C.-S., Park, K.-W., Kim, J.-H., Kim, T.-Y., Kim, J.-Y., Kang, H.-J., Chae, I.-H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.694778 · Cited by 255
Thrombospondin Type 1 Repeats Interact with Matrix Metalloproteinase 2
Bein, K., & Simons, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003834200 · Cited by 255
Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes
Lolmède, K., Durand de Saint Front, V, Galitzky, J., Lafontan, M., & Bouloumié, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802407 · Cited by 224
Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs
Lozito, T. P., & Tuan, R. S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22344 · Cited by 171
Zaman, A. K. M. T., Fujii, S., Sawa, H., Goto, D., Ishimori, N., Watano, K., Kaneko, T., Furumoto, T., Sugawara, T., Sakuma, I., et al. (2001) · Circulation · doi:10.1161/01.cir.103.25.3123 · Cited by 68
(2014) · PubMed · Cited by 63
Lang, R., Braun, M., Sounni, N. E., Noel, A., Frankenne, F., Foidart, J.-M., Bode, W., & Maskos, K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.022 · Cited by 42
Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32
Metadata
- Authors
- Stetler-Stevenson, W. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-05-01
- Volume
- 103
- Issue
- 9
- Pages
- 1237-1241
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1984584032
- Cited by
- 842
- References
- 22
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.